Follow
Mohammad AlSaggar
Title
Cited by
Cited by
Year
Physical methods for gene transfer
M Alsaggar, D Liu
Advances in genetics 89, 1-24, 2015
472015
Dual outcomes of rosiglitazone treatment on fatty liver
M Gao, Y Ma, M Alsaggar, D Liu
The AAPS Journal 18, 1023-1031, 2016
442016
Inhibition of S-adenosylmethionine-dependent methyltransferase attenuates TGFβ1-induced EMT and metastasis in pancreatic cancer: putative roles of miR-663a and miR-4787-5p
HR Mody, SW Hung, M AlSaggar, J Griffin, R Govindarajan
Molecular Cancer Research 14 (11), 1124-1135, 2016
382016
Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice
M Alsaggar, S Bdour, Q Ababneh, T El-Elimat, N Qinna, KH Alzoubi
BMC Pharmacology and Toxicology 21, 1-8, 2020
372020
Interferon beta overexpression attenuates adipose tissue inflammation and high-fat diet-induced obesity and maintains glucose homeostasis
M Alsaggar, M Mills, D Liu
Gene therapy 24 (1), 60-66, 2017
352017
Organ-based drug delivery
M Alsaggar, D Liu
Journal of Drug Targeting 26 (5-6), 385-397, 2018
322018
Design and characterization of a new hybrid peptide from LL-37 and BMAP-27
Y Al Tall, A Abualhaijaa, M Alsaggar, A Almaaytah, M Masadeh, ...
Infection and drug resistance, 1035-1045, 2019
212019
Differential growth and responsiveness to cancer therapy of tumor cells in different environments
M Alsaggar, Q Yao, H Cai, D Liu
Clinical & experimental metastasis 33, 115-124, 2016
102016
Functional and toxicological evaluation of MAA-41: a novel rationally designed antimicrobial peptide using hybridization and modification methods from LL-37 and BMAP-28
M Masadeh, A Ayyad, R Haddad, M Alsaggar, K Alzoubi, N Alrabadi
Current Pharmaceutical Design 28 (26), 2177-2188, 2022
62022
The ultrashort peptide OW: a new antibiotic adjuvant
Y Al Tall, A Abualhaijaa, MT Qaoud, M Alsaggar, M Masadeh, KH Alzoubi
Current pharmaceutical biotechnology 20 (9), 745-754, 2019
52019
SAMA peptide, a rationally designed antimicrobial peptide
M Alsaggar, A Al-Tarawneh, Y Al Tall, M Al-Hazabreh
Journal of Applied Pharmaceutical Science 12 (1), 182-189, 2021
32021
Liver-targeted gene and cell therapies: an overview
M Alsaggar, D Liu
Gene Therapy and Cell Therapy Through the Liver: Current Aspects and Future …, 2016
22016
Sumc (Rhus coriaria L.) fruit ameliorates paracetamol-induced hepatotoxicity
T El-Elimat, BK Al-Tal, NA Al-Sawalha, M Alsaggar, SD Nusair, R Al‐Qiam, ...
Food Bioscience 52, 102488, 2023
12023
An antibacterial novel peptide based on cecropin and MAP-27: Design and characterization
MM Masadeh, AEA AL-Kahsi, R Haddad, M Alsaggar, KH Alzoubi, ...
Journal of Applied Pharmaceutical Science 13 (3), 141-152, 2023
2023
Identification and characterization of bacteria isolated from patients with cystic fibrosis in Jordan
N Alshraiedeh, F Atawneh, R Bani-Salameh, R Alsharedeh, Y Al Tall, ...
Annals of Medicine 54 (1), 2795-2803, 2022
2022
HAZ, a novel peptide with broad-spectrum antibacterial activity
M Alsaggar, M Al-Hazabreh, Y Al Tall, A Al-Tarawneh, RS Darweesh, ...
Saudi Pharmaceutical Journal 30 (11), 1652-1658, 2022
2022
Online First
MM Masadeh, AEA AL-Kahsi, R Haddad, M Alsaggar, KH Alzoubi, ...
2022
Hydrodynamic delivery for cancer and obesity research
MH Alsaggar
University of Georgia, 2016
2016
234. Hydrodynamic Cell Delivery for Assessment of Tumor Growth and Drug Sensitivity in Different Organs and Microenvironment
MH Alsaggar, Q Yao, D Liu
Molecular Therapy 23, S92, 2015
2015
Future perspective: toward targeting at the cellular level
Y Alhamhoom, M Alsaggar, D Liu
Advances and Challenges in the Delivery of Nucleic Acid Therapeutics Volume 2, 3, 0
The system can't perform the operation now. Try again later.
Articles 1–20